PHASE II TRIAL OF PATUPILONE IN PATIENTS WITH BREAST CANCER BRAIN METASTASES

被引:0
|
作者
Peereboom, D. M. [1 ]
Conlin, A. K. [2 ]
Seidman, A. D. [2 ]
Brewer, C. [1 ]
机构
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1077 / 1077
页数:1
相关论文
共 50 条
  • [41] Brain metastases in patients with advanced breast cancer
    Sanna, G.
    Franceschelli, L.
    Rotmensz, N.
    Botteri, E.
    Adamoli, L.
    Marenghi, C.
    Munzone, E.
    Rocca, M. Cossu
    Verri, E.
    Minchella, I.
    Medici, M.
    Catania, C.
    Magni, E.
    Goldhirsch, A.
    Nole, F.
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2865 - 2869
  • [42] Phase II study of docetaxel in patients with liver metastases from breast cancer
    Coleman, RE
    Howell, A
    Eggleton, SPH
    Maling, SJ
    Miles, DW
    ANNALS OF ONCOLOGY, 2000, 11 (05) : 541 - 546
  • [43] A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases
    Fabio M. Iwamoto
    Antonio M. Omuro
    Jeffrey J. Raizer
    Craig P. Nolan
    Adília Hormigo
    Andrew B. Lassman
    Igor T. Gavrilovic
    Lauren E. Abrey
    Journal of Neuro-Oncology, 2008, 87 : 85 - 90
  • [44] A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases
    Iwamoto, Fabio M.
    Omuro, Antonio M.
    Raizer, Jeffrey J.
    Nolan, Craig P.
    Hormigo, Adilia
    Lassman, Andrew B.
    Gavrilovic, Igor T.
    Abrey, Lauren E.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 87 (01) : 85 - 90
  • [45] Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    McDermott, David F.
    Kramer, Amy
    Giles, Lydia
    Gramlich, Kristi
    Carberry, Mary
    Troxel, Andrea B.
    Letrero, Richard
    Nathanson, Katherine L.
    Atkins, Michael B.
    O'Dwyer, Peter J.
    Flaherty, Keith T.
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7711 - 7718
  • [46] Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
    Christodoulou, C
    Bafaloukos, D
    Kosmidis, P
    Samantas, E
    Bamias, A
    Papakostas, P
    Karabelis, A
    Bacoyiannis, C
    Skarlos, DV
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 249 - 254
  • [47] Patupilone for the treatment of recurrent/progressive brain metastases in patients (pts) with non-small cell lung cancer (NSCLC): An open-label phase II study
    Abrey, L. E.
    Wen, P.
    Govindan, R.
    Reimers, H.
    Rigas, J. R.
    Robins, H. I.
    Allen-Freda, E.
    Gao, B.
    Ko, J.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] A phase I/II trial of irinotecan and whole brain radiation therapy in patients with brain metastases.
    Chen, AY
    Ryu, JK
    Lau, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 127S - 127S
  • [49] Phase II trial of brain MRI surveillance in stage IV breast cancer
    Ahmed, Kamran A.
    Kim, Youngchul
    Armaghani, Avan J.
    Arrington, John A.
    Costa, Ricardo L.
    Czerniecki, Brian J.
    Diaz, Roberto
    Dowell, Robin A.
    Extermann, Martine
    Forsyth, Peter A.
    Lee, Kimberley T.
    Loftus, Loretta
    Mills, Matthew N.
    Phuoc, Vania H.
    Rosa, Marilin
    Soliman, Hatem H.
    Sam, Christine S.
    Washington, Iman R.
    Soyano, Aixa E.
    Han, Hyo S.
    NEURO-ONCOLOGY, 2025,
  • [50] A prospective phase II trial on reirradiation of brain metastases with radiosurgery
    Maranzano, Ernesto
    Terenzi, Sara
    Anselmo, Paola
    Casale, Michelina
    Arcidiacono, Fabio
    Loreti, Fabio
    Di Marzo, Alessandro
    Draghini, Lorena
    Italiani, Marco
    Trippa, Fabio
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 17 : 1 - 6